"SpongoadenosineSYNCI" . . "Vidarabine"^^ . "ArabinosyladenineSYNCI" . "Vira-ABRNCI" . "Arasena-AFBNCI" . . "39150"^^ . "9-Beta-D-arabinofuranosyladenine MonohydrateSNNCI" . . "CHEBI:9978"^^ . "Vidarabine"^^ . "24356-66-9"^^ . "VidarabinePTNCI" . "FDA"^^ . "Beta Ara-ASYNCI" . "Pharmacologic Substance"^^ . "AraadenosineSYNCI" . "Adenine ArabinosideSYNCI" . "C929"^^ . "SpongoadenosineSYDTPNSC0404241" . . "39150"^^ . "9-Beta-D-arabinofuranosyl-9H-purine-6-amine MonohydrateSNNCI" . . "VIDARABINEPTFDAFA2DM6879K" . "404241"^^ . . "Ara-AABNCI" . . "Nucleic Acid, Nucleoside, or Nucleotide"^^ . "Vidarabine"^^ . "CI-673CNNCI" . "C0042646"^^ . "FA2DM6879K"^^ . "VIDARABINESYDTPNSC0247519" . "C10H13N5O4.H2O"^^ . "A nucleoside analog with activity against herpes simplex virus and varicella zoster virus. Vidarabine is converted to a monophosphate by viral thymidine kinase and is further modified to a triphosphate form by host enzymes. Vidarabine triphosphate directly inhibits DNA polymerase and also acts as a chain terminator in DNA replication.NCI" .